RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 90 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,062,000 | -51.0% | 234,482 | -50.1% | 1.64% | -44.0% |
| Q2 2019 | $10,329,000 | -7.0% | 469,482 | +15.9% | 2.92% | -26.8% |
| Q1 2019 | $11,102,000 | +3.3% | 405,026 | +1.3% | 3.99% | -19.1% |
| Q4 2018 | $10,752,000 | -47.1% | 400,000 | -42.6% | 4.94% | -26.0% |
| Q3 2018 | $20,329,000 | -9.9% | 696,903 | -3.5% | 6.66% | -13.4% |
| Q2 2018 | $22,567,000 | +467.0% | 721,903 | +261.0% | 7.69% | +366.2% |
| Q1 2018 | $3,980,000 | -21.7% | 200,000 | +14.3% | 1.65% | -53.7% |
| Q4 2017 | $5,086,000 | – | 175,000 | – | 3.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |